Entasis Therapeutics Holdings Inc. (ETTX) Stock Surges Following Promising Topline Results from ATTACK Clinical Trial
Entasis Therapeutics Holdings Inc. (ETTX) stock prices were down by 1.27% as of the market closing on October 18th, 2021. This brought the price per